Interpreting the Epstein-Barr virus (EBV) epigenome using high-throughput data

Viruses

Volumn 5, Issue 4, 2013, Pages 1042-1054

  Arvey, Aaron ^a   Tempera, Italo ^b   Lieberman, Paul M ^c  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WISTAR INSTITUTE   (United States)

Author keywords

Chromatin; CTCF; Epstein Barr virus; Gammaherpesvirus; Histone modification; OriP

Indexed keywords

COHESIN; DEOXYRIBONUCLEASE I; EBF PROTEIN; MICROCOCCAL NUCLEASE; MICROCOCCAL NUCLEASE I; OCTAMER TRANSCRIPTION FACTOR 2; PBX3 PROTEIN; PROTEIN BCL 3; PROTEIN C FOS; RXRA PROTEIN; TCF12 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CTCF; TRANSCRIPTION FACTOR ELF 1; TRANSCRIPTION FACTOR JUND; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR YY1; UNCLASSIFIED DRUG; ZNF143 PROTEIN;

BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; DNA METHYLATION; DNA REPLICATION; EPIGENETICS; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; GENE MAPPING; GENETIC ANALYSIS; HETEROCHROMATIN; HIGH THROUGHPUT SEQUENCING; HISTONE MODIFICATION; HUMAN; NONHUMAN; NOTE; NUCLEOTIDE SEQUENCE; ORIGIN OF LATENT REPLICATION; VIRUS GENOME;

EPIGENESIS, GENETIC; EPIGENOMICS; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS;

HUMAN HERPESVIRUS 4;

EID: 84875948453     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v5041042     Document Type: Note

References (34)

1. Arvey, A.; Tempera, I.; Tsai, K.; Chen, H.S.; Tikhmyanova, N.; Klichinsky, M.; Leslie, C.; Lieberman, P.M. An atlas of the epstein-barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell. Host. Microbe. 2012, 12, 233-245.
2. Kieff, E. Epstein-Barr Virus and its replication. 5th ed.; Wolters Kluwer Health/Lippincott Williams & Wilkins: Philadelphia, 2007; p 2 v. (xix, 3091, 86 p.).
3. Rickinson, A. B., and Kieff, E., Epstein-Barr Virus. 5th ed.; Wolters Kluwer Health/Lippincott Williams & Wilkins: Philadelphia, 2007; p 2 v. (xix, 3091, 86 p.).
4. Rowe, M.; Lear, A.L.; Croom-Carter, D.; Davies, A.H.; Rickinson, A.B. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J. Virol. 1992, 66, 122-131.
5. Yates, J.L.; Guan, N. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J. Virol. 1991, 65, 483-488.
6. Amon, W.; Farrell, P.J. Reactivation of Epstein-Barr virus from latency. Rev. Med. Virol. 2005, 15, 149-156.
7. Cai, X.; Schafer, A.; Lu, S.; Bilello, J.P.; Desrosiers, R.C.; Edwards, R.; Raab-Traub, N.; Cullen, B.R. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2006, 2, e23.
8. Li, H.; Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinform. 2009, 25, 1754-1760.
9. Langmead, B.; Trapnell, C.; Pop, M.; Salzberg, S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome. Biol. 2009, 10, R25.
10. Jankelevich, S.; Kolman, J.L.; Bodnar, J.W.; Miller, G. A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain. Embo J. 1992, 11, 1165-1176.
11. Kundaje, A.; Kyriazopoulou-Panagiotopoulou, S.; Libbrecht, M.; Smith, C.L.; Raha, D.; Winters, E.E.; Johnson, S.M.; Snyder, M.; Batzoglou, S.; Sidow, A. Ubiquitous heterogeneity and asymmetry of the chromatin environment at regulatory elements. Genome. Res. 2012, 22, 1735-1747.
12. Baer, R.; Bankier, A.T.; Biggin, M.D.; Deininger, P.L.; Farrell, P.J.; Gibson, T.J.; Hatfull, G.; Hudson, G.S.; Satchwell, S.C.; Seguin, C.; et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984, 310, 207-211.
13. Dyson, P.J.; Farrell, P.J. Chromatin structure of Esptein-Barr virus. J. Gen. Virol. 1985, 66, 1931-1940.
14. Pepke, S.; Wold, B.; Mortazavi, A. Computation for ChIP-seq and RNA-seq studies. Nat. Methods. 2009, 6, 22-32.
15. Shilatifard, A. Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation. Curr. Opin. Cell. Biol. 2008, 20, 341-348.
16. Toth, Z.; Maglinte, D.T.; Lee, S.H.; Lee, H.R.; Wong, L.Y.; Brulois, K.F.; Lee, S.; Buckley, J.D.; Laird, P.W.; Marquez, V.E.; Jung, J.U. Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog. 2010, 6, e1001013.
17. Prasanth, S.G.; Shen, Z.; Prasanth, K.V.; Stillman, B. Human origin recognition complex is essential for HP1 binding to chromatin and heterochromatin organization. Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 15093-15098.
18. Chakraborty, A.; Shen, Z.; Prasanth, S.G. "ORCanization" on heterochromatin: linking DNA replication initiation to chromatin organization. Epigenetics 2011, 6, 665-670.
19. Onder, T.T.; Kara, N.; Cherry, A.; Sinha, A.U.; Zhu, N.; Bernt, K.M.; Cahan, P.; Marcarci, B.O.; Unternaehrer, J.; Gupta, P.B.; Lander, E.S.; Armstrong, S.A.; Daley, G.Q. Chromatin-modifying enzymes as modulators of reprogramming. Nature 2012, 483, 598-602.
20. Wakeman, T.P.; Wang, Q.; Feng, J.; Wang, X.F. Bat3 facilitates H3K79 dimethylation by DOT1L and promotes DNA damage-induced 53BP1 foci at G1/G2 cell-cycle phases. EMBO J. 2012, 31, 2169-2181.
21. Phillips, J.E.; Corces, V.G. CTCF: master weaver of the genome. Cell 2009, 137, 1194-1211.
22. Ohlsson, R.; Lobanenkov, V.; Klenova, E. Does CTCF mediate between nuclear organization and gene expression? Bioessays 2010, 32, 37-50.
23. Kang, H.; Wiedmer, A.; Yuan, Y.; Robertson, E.; Lieberman, P.M. Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation. PLoS Pathog. 2011, 7, e1002140.
24. Kang, H.; Lieberman, P.M. Mechanism of Glycyrrhizic Acid Inhibition of Kaposi's Sarcoma-Associated Herpesvirus: Disruption of CTCF-Cohesin-Mediated RNA Polymerase II Pausing and Sister Chromatid Cohesion. J. Virol. 2011, 85, 11159-11169.
25. Tempera, I.; Klichinsky, M.; Lieberman, P.M. EBV latency types adopt alternative chromatin conformations. PLoS Pathog. 2011, 7, e1002180.
26. Atchison, M.; Basu, A.; Zaprazna, K.; Papasani, M. Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects. Crit. Rev. Oncog. 2012, 16, 143-161.
27. Wang, J.; Sugden, B. Origins of bidirectional replication of Epstein-Barr virus: Models for understanding mammalian origins of DNA synthesis. J. Cell. Biochem. 2005, 94, 247-256.
28. Lindner, S.E.; Sugden, B. The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells. Plasmid. 2007, 58, 1-12.
29. Zhou, J.; Chau, C.M.; Deng, Z.; Shiekhattar, R.; Spindler, M.P.; Schepers, A.; Lieberman, P.M. Cell cycle regulation of chromatin at an origin of DNA replication. Embo J. 2005, 24, 1406-1417.
30. Kalla, M.; Hammerschmidt, W. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus. Eur. J. Cell. Biol. 2011, 91, 65-69.
31. Tempera, I.; Wiedmer, A.; Dheekollu, J.; Lieberman, P.M. CTCF prevents the epigenetic drift of EBV latency promoter Qp. PLoS Pathog. 2010, 6, e1001048.
32. Hughes, D.J.; Marendy, E.M.; Dickerson, C.A.; Yetming, K.D.; Sample, C.E.; Sample, J.T. Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency. J. Virol. 2011, 86, 1034-1045.
33. Bergbauer, M.; Kalla, M.; Schmeinck, A.; Gobel, C.; Rothbauer, U.; Eck, S.; Benet-Pages, A.; Strom, T.M.; Hammerschmidt, W. CpG-methylation regulates a class of Epstein-Barr virus promoters. PLoS Pathog. 2010, 6, 1001114.
34. Ramasubramanyan, S.; Kanhere, A.; Osborn, K.; Flower, K.; Jenner, R.G.; Sinclair, A.J. Genome-Wide Analyses of Zta Binding to the Epstein-Barr Virus Genome Reveals Interactions in both Early and Late Lytic Cycles and an Epigenetic Switch Leading to an Altered Binding Profile. J. Virol. 2012, 86, 12494-12502.